Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 1/20 | 0.58 |
| ▸ | RARB | P10826 | 3/20 | 0.57 |
| ▸ | MRGPRX4 | Q96LA9 | 2/20 | 0.53 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.53 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.53 |
| ▸ | TP53 | P04637 | 1/20 | 0.53 |
| ▸ | PKM | P14618 | 1/20 | 0.53 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.53 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.53 |
| ▸ | RELA | Q04206 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | PPARG | P37231 | 1/20 | 0.52 |
| ▸ | PPARA | Q07869 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31124111 | 1.00 | FOLH1 (0.58) | FOLH1RARBMRGPRX4CYP4F2CYP4A11 | |
| SCHEMBL443913 | 0.95 | RARB (0.58) | FOLH1RARBPPARGPPARA | |
| SCHEMBL15766204 | 0.93 | RARB (0.59) | RARBPPARGPPARA | |
| SCHEMBL1876486 | 0.93 | RARB (0.59) | RARBPPARGPPARA | |
| SCHEMBL27414335 | 0.93 | RARB (0.59) | RARBPPARGPPARA | |
| SCHEMBL15174619 | 0.93 | RARB (0.59) | RARBPPARGPPARA | |
| SCHEMBL11442846 | 0.93 | RARB (0.59) | RARBPPARGPPARA | |
| SCHEMBL289254 | 0.93 | RARB (0.59) | RARBPPARGPPARA | |
| SCHEMBL9812591 | 0.92 | RARB (0.58) | RARBPPARGPPARA | |
| SCHEMBL28369070 | 0.90 | BCL2 (0.56) | RARB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119591646-A | 3- (3-Pyridine) -5-R-benzoic acid coordinated catalyst, composite catalyst, preparation method and application | 上海元革新材料科技有限公司 | 2025-03-11 | — | — | CN | claimed |
| EP-2785752-B1 | INTERNAL ELECTRON DONOR FOR OLEFIN POLYMERIZATION CATALYSTS, METHOD OF MAKING AND USING THE SAME | BRASKEM AMERICA INC (US) | 2023-05-31 | — | — | EP | claimed |
| EP-2516479-B1 | NEW INTERNAL AND EXTERNAL DONOR COMPOUNDS FOR OLEFIN POLYMERIZATION CATALYSTS | BASF CORP (US) | 2016-04-20 | — | — | EP | claimed |
| CN-122010800-A | A kind of substituted thiophenol is a process for the selective alkylation of | 大连理工大学 | 2026-05-12 | — | — | CN | disclosed |
| US-20250305210-A1 | FIBER-TREATING AGENT | KAO CORPORATION (JP) | 2025-10-02 | — | — | US | disclosed |
| WO-2025079658-A1 | FIBER TREATMENT AGENT | 花王株式会社 | 2025-04-17 | — | — | WO | disclosed |
| EP-4528021-A1 | FIBER-TREATING AGENT | Kao Corporation (JP) | 2025-03-26 | — | — | EP | disclosed |
| CN-119591646-A | 3- (3-Pyridine) -5-R-benzoic acid coordinated catalyst, composite catalyst, preparation method and application | 上海元革新材料科技有限公司 | 2025-03-11 | — | — | CN | disclosed |
| CN-119234061-A | Fiber treatment agent | 花王株式会社 | 2024-12-31 | — | — | CN | disclosed |
| US-12012475-B2 | Method of olefin polymerization using alkane-soluble non-metallocene precatalyst | DOW GLOBAL TECHNOLOGIES LLC (US) | 2024-06-18 | — | — | US | disclosed |
| CN-112823163-B | Alkane soluble non-metallocene precatalyst | 陶氏环球技术有限责任公司 | 2024-04-19 | — | — | CN | disclosed |
| EP-1824819-B1 | PYRROLIDIN-2-ONE DERIVATIVES FOR USE AS DP1 RECEPTOR AGONISTS | MERCK SERONO SA (CH) | 2010-01-20 | — | — | EP | disclosed |
| CN-1315813-C | 2-oxo-4H-3, 1-benzoxazin-4-ones for the treatment of obesity | ALIZYME THERAPEUTICS LTD (GB) | 2007-05-16 | — | — | CN | disclosed |
| CN-1915981-A | 2-oxy-benzoxazinone derivatives for the treatment of obesity | ALIZYME THERAPEUTICS LTD (GB) | 2007-02-21 | — | — | CN | disclosed |
| EP-0454501-B1 | Benzylidenethiazolidine derivatives, their preparation and their use for the inhibition of lipid peroxides | SANKYO CO (JP) | 2001-09-05 | — | — | EP | disclosed |
| EP-0839812-A1 | Preparation of benzylthiazolidine derivatives | Sankyo Company Limited (JP) | 1998-05-06 | — | — | EP | disclosed |
| US-5422360-A | Hydrazonoimidazolidin-4-one derivatives; treatment of diabetes and aging disorders | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1995-06-06 | — | — | US | disclosed |
| US-5387596-A | Treating arteriosclerosis | SANKYO COMPANY, LIMITED (JP) | 1995-02-07 | — | — | US | disclosed |
| EP-0531812-A1 | Maillard reaction inhibitor, process for producing it, composition containing it and the use thereof | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1993-03-17 | — | — | EP | disclosed |
| EP-0454501-A2 | Benzylidenethiazolidine derivatives, their preparation and their use for the inhibition of lipid peroxides | Sankyo Company Limited (JP) | 1991-10-30 | — | — | EP | disclosed |